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The Importance of Psychoneuroimmunology for Social Workers
Abstract
A wealth of information regarding how the immune system can influence the brain and result in changes
in mood and behavior has accumulated. Inflammation is a causal factor in some cases of major
depression and psychotic disorders, and predicts whether trauma will result in Post Traumatic Stress
Disorder (PTSD). Fortunately, studies in the area of psychoneuroimmunology have also suggested ways
to decrease inflammation. Knowledge of this information is vital for social workers so that the impact of
their interventions can be maximized. Moreover, for macro-practice social workers the information
underscores the importance of access to nutritional food, access to safe places for exercise, and the time
for food preparation and exercise, which should be considered as social justice issues.
Key Words: psychoneuroimmunology, inflammation in depression, inflammation in psychosis,
microbiome, vaccinating against PTSD, yoga and distress
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The Importance of Psychoneuroimmunology for Social Workers
The emerging field of psychoneuroimmunology investigates how the immune system alters
behavior, mood, the brain, and hormones. New data suggest that inflammation plays a causal role in at
least some cases of major depression, Post Traumatic Stress Disorder (PTSD), psychosis, as well as more
ephemeral variations in mood. Inflammation refers to “the local accumulation of fluid, plasma proteins,
and white blood cells that is initiated by physical injury, infection, or a local immune response” (Murphy,
2012, p. 805). This paper will review the evidence for inflammation playing a role in a broad range of
behavior. This paper will also review the findings regarding those life style changes that are associated
with a decrease inflammation. Social workers are in a unique position to assist clients in making these
salubrious life-style changes.
Before getting started, a little preliminary information on the immune system may help to clarify
later discussion. The immune system, that is the events orchestrated by white blood cells (leukocytes), is
divided into two branches: the innate system and the adaptive system. The innate system involves the
types of white blood cells that are involved in creating inflammation. Although this system is vital for
fighting bacterial infections, it needs to be quickly downregulated when the pathogen is cleared because
these cells release reactive oxidative species that can destroy a pathogen but also the host’s cells. In
contrast to the innate system, the adaptive system is recruited with vaccination and involves antibody
production. The leukocytes involved in the adaptive system only target one specific protein (usually from
a pathogen) and are less involved in creating inflammation. Work by Steven Cole (2014) suggests that in
some ways the adaptive and innate systems are inversely related. Cole gathers people’s white blood cells
and then investigates which genes are being expressed and used to make proteins. For those persons
whose fight/flight systems are strongly activated, proteins involved in creating inflammation are
upregulated and proteins of the adaptive system needed for fighting cancer and viruses are
downregulated. This pattern is also seen in those who are socially disconnected (Moleni et al., 2015).
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Conversely, Cole found that people who have higher levels of psychological well being, which included
having a sense of purpose, were stronger on the adaptive arm of the immune system and less strong on
innate/inflammation arm (Fredrickson et al., 2015; Frederickson et al., 2013). When the word
“inflammation” is employed in this paper, it generally refers to events orchestrated by the innate immune
system.
Depression
Findings Suggesting that Inflammation Plays a Role in Depression
Inflammatory markers in blood are on average higher in those with depression compared to
healthy individuals (Raison, Capuron, & Miller, 2006; Schiepers, Wichers, & Maes, 2005) and this was
confirmed in a recent meta-analysis (Köhler et al., 2017). Setiawan et al. (2015) imaged activated white
blood cells in brain and found that those with depression, on average, had more activated white blood
cells. Other studies have reported on the percentage of the sample of depressed individuals showing
elevations in inflammatory markers. Raison et al. (2013) found elevations in 45% of their depressed
sample and Tartter, Hammen, Bower, Brennan, and Cole (2015) reported elevations in 1/3 of depressed
persons.
Several studies have found that genetic variations associated with enhanced inflammatory
capacity interact with childhood maltreatment or significant life stressor to increase the risk for the
emergence of depression (Cohen-Woods et al., 2018; Kovacs et al., 2016). Animal work is consistent
with strong inflammatory capacity being a risk factor for development of depressed behavior following
the occurrence of a social stressor. Hodes et al. (2014) stimulated the white blood cells of their animals to
determine which animals exhibited a strong inflammatory response and which animals did not. They then
subjected their animals to social defeat. Those animals with the stronger inflammatory responses
exhibited higher levels of depression in response to the social defeat. Moreover, when the strongly
releasing leukocytes were transferred to the resilient animals, the resilient animals appeared more
depressed after social defeat.

Psychoneuroimmunology

5

Raison et al. (2013) used an antibody to a major pro-inflammatory hormone to treat depression.
For those with evidence of inflammation, the antibody resulted in a significant decline in depressive
symptoms, although those depressed individuals with elevations in inflammatory factors often fail to
respond to traditional antidepressants (Kiraly et al., 2017). Various other anti-inflammatories (aspirin,
COX-2 inhibitors, ketamine) have demonstrated efficacy in ameliorating depression (Hodes, Kana,
Menard, Merad, & Russo, 2015).
The Manipulated Variable Findings
Inflammation can be created by injecting the wall of a bacterium (lipopolysaccharide or LPS)
under the skin. In work with animals, LPS injection results in depressed behavior (Dantzer, O’Connor,
Lawson, & Kelley, 2011; Dantzer et al., 1998). A number of researchers have injected LPS into human
subjects and noted the following: increases in depressed mood, anxiety, and memory problems (Kullman
et al., 2013; Yirmiya et al., 2000); more activity in anxiety centers of the brain when an individual views
angry faces (Inagaki, Muscatell, Irwin, Cole, & Eisenberger, 2012); a lowered threshold for physical pain
(Wegner et al, 2014); less activity in brain reward circuitry in response to money (Eisenberger et al.,
2011); and more activation in social pain areas of the brain in response to social exclusion, although this
heightened brain activation was only noted in females with induced elevations in inflammatory markers
(Eisenberger, Inagaki, Rameson, Mashal, & Irwin, 2009);
Interferon alpha, an inflammatory hormone, has been used as a treatment for melanoma and
hepatitis. Across studies, 20 to 50% of persons receiving IFN-alpha become depressed (Raison, Dantzer
et al., 2010).
The Relationship between Stress and Inflammation
A wide variety of types of stress are associated with inflammation. Lonely people (Cole et al.,
2007) and caregivers of Alzheimer’s patients (Kiecolt-Glaser et al., 2003; Miller et al., 2008; von Kanel et
al., 2006) exhibit elevations in blood markers of inflammation. In a study of British civil service workers,
all of whom had access to health care, those who earned less and had less control over their work
environments exhibited higher blood inflammatory markers after controlling for diet and smoking
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(Steptoe et al., 2003). Similarly, those in low status jobs exhibit higher levels of inflammatory markers
(Powell et al., 2013) as do those of higher social status who experience financial stress (Sturgeon et al.,
2016)
By inducing stress in subjects, researchers have shown that there is a causal connection between
stress and inflammation. In an animal model of major depression, researchers have subjected rodents to
inescapable shock. Subsequent to shock, the animals exhibit signs of depression (less activity, less
consumption of sweetened liquid) and elevations in brain levels of inflammatory hormones (Maier &
Watkins, 1998; Wohleb, Franklin, Iwata, & Duman, 2016). However, if a chemical sponge for an
inflammatory hormone is placed into the brain, the rodents behave normally (Maier & Watkin, 1998).
Researchers have also stressed people and then measured markers of inflammation. Pace et al.
(2006) used the Trier Social Stress Test during which people give a speech about an embarrassing
moment to a hostile audience. This procedure reliably elevates markers of inflammation in blood.
Researchers have also had people play an interactive cyberball game on the computer from which they are
suddenly excluded. The socially excluded exhibit activation of stress/pain centers in brain (Eisenberger,
Lieberman, & Williams, 2003). Moreover, the level of brain activation to the cyberball social exclusion
correlates with magnitude of inflammatory activation as measured during the Trier social stressor test
(Slavich, Way, Eisenberger, & Taylor, 2010). There is reason to believe that the inflammatory factors
are causing the activation in the brain’s stress/pain centers in the cyberball task. If acetaminophen, which
decreases inflammation, is provided before playing the cyberball game, then activation in the stress/pain
areas of the brain fails to occur (DeWall et al., 2010).
Vulnerability to Post Traumatic Stress Disorder
Prior levels of inflammation may be a risk factor for PTSD given subsequent occurrence of
trauma. Work with people has confirmed this hypothesis (Eraly et al., 2014). Moreover, consistent with
inflammation playing a causal role in the emergence of PTSD, an early or steeper rise in inflammatory
factors after trauma predicts later symptoms of PTSD (Pervanidou et al., 2007; Sumner et al., 2018).
A study by Reber et al. (2016) raised the possibility of being able to vaccinate against PTSD.
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Exposure to a particular type of bacteria can elicit an anti-inflammatory response and can activate neurons
called anti-panic neurons in the brain (Lowry et al., 2007). Reber et al. vaccinated mice with this bacteria
and then subjected them to intrusion by a predator. The vaccinated animals, compared to the sham
vaccinated, displayed little anxiety and were far less submissive. Using the same vaccination procedure,
Fox et al. (2017) found that the vaccinated animals were faster to extinguish a conditioned fear.
The anti-panic neurons that are activated by the bacteria can also be activated by heat (Hale et al.,
2017). Janssen et al. (2016) tested heat as an antidepressant, increasing people’s body temperature to 101
degrees which required about 20 minutes of heat application. This intervention ameliorated depression
for about six weeks.
Psychosis
The proximal cause of hearing voices is caused by too much dopamine release. However, Grace
and Gomes (2018) argue that defects in the dopamine system have not been found in those with
psychosis. In contrast, there is a great deal of evidence implicating disturbances and loss of neurons
located in the hippocampus that control dopamine release (Grace, 2016). The activity of these particular
neurons, called fast-spiking GABA interneurons, is driven by NMDA receptors on these neurons.
Inflammation and associated reactive oxidative species released during inflammation can interfere with
NMDA signaling and dampen the activity of the fast-spiking GABA interneurons or result in their death
(Chung, Fish, & Lewis, 2016; Do, Cabungcal, Frank, Steullet, & Cuenod, 2009; Grace, 2016; Miller &
Goldsmith, 2017). (The details of this story are reviewed in Littrell, 2015, Chapter 6).
Much evidence is available attesting to brain inflammation being associated with psychosis.
Proteins associated with inflammation have been found in the blood of those with schizophrenia (Yee et
al., 2017). In a location more proximal to the brain, inflammatory factor elevations have been noted in
the cerebrospinal fluid in many studies (Müller, Weidinger, Leitner, & Schwarz, 2015; Wang & Miller,
2017). Van Rees et al. (2018) took blood from first-episode, drug naïve persons with psychosis and
mixed them with brain white blood cells (called microglia). The blood of those with psychosis resulted in
activation of the microglia, although blood from controls did not. Consistent with the idea that the
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presence of substances that can activate white blood cells resulting in symptoms of psychosis, relapses to
hearing voices is often occasioned by urinary tract infections (Miller et al., 2013). Finally, it is now
possible to image (see) activated white blood cells in the brain. Several such imaging studies have found
evidence of activated white blood cells in brain in non-medicated persons with psychosis (Bloomfield et
al., 2016; Doorduin et al., 2009; Van Berckel et al., 2008), however, there are failures to replicate (Miller
& Goldsmith, 2017).
A history of trauma has been noted in those for whom psychosis later emerged (Aas et al., 2017,
Heins et al., 2011). As discussed earlier, stressful events do elevate inflammatory factors in the brain
(Jiang et al., 2013). Thus, inflammation may explain the link between trauma and psychosis.
Inflammation might also explain the many studies showing that an inflammatory state in the mother
during gestation is associated with elevated risk for psychosis in the offspring (Müller et al., 2015) and
the fact that variants of genes coding for immune system proteins elevate the risk for psychosis (Müller et
al., 2015; Pouget, 2018). Finally, in those treated with an inflammatory hormone (interferon alpha) for
conditions such as hepatitis C or melanoma, although the emergence of depression was more common, in
one study 0.1% developed psychosis and in another 0.4% developed psychosis. In both samples
psychosis resolved with the discontinuation of the inflammatory hormone therapy (Miller & Buckley,
2016).
In an attempt to prevent the emergence of psychosis in those youth at risk, several interventions
have been attempted. Antipsychotic medications were not effective. However, omega-3s, whose antiinflammatory properties are well-recognized (Serhan, 2017), did reduce the emergence of psychosis in
one cohort at 6.7 year follow-up (9.8% versus 40%) (Amminger, Schafer, Schlogelhofer, Klier, &
McGorry, 2015), although not in another cohort at one year follow-up (McGorry et al., 2017).
Moreover, higher blood levels of omega-3 were predictive of an absence of psychosis at seven-year
follow-up (Mossaheb et al., 2017). Anti-inflammatory approaches have been successful in reducing
symptoms of psychosis whether in those carrying a diagnosis of bipolar (Husain, Strawbridge, Stokes, &

Psychoneuroimmunology

9

Young, 2017) and schizophrenia (Melbourne, Feiner, Rosen, & Sharma, 2017; Miller & Buckley, 2016;
Sommer et al., 2014).
A particularly poignant illustration of the profound impact of brain inflammation on behavior is
the story of Susannah Cahalan, a journalist. Susannah (2012) describes her journey into psychosis in her
book, Brain on Fire: My month of madness. Susannah details her symptoms of mania, paranoia,
production of verbal word-salad, and catatonia through which she cycled. Successful treatment was only
achieved when confirmation of brain inflammation was made and addressed. In terms of explanation for
why Susannah experienced inflammation, Susannah had had a bout of melanoma earlier which resulted in
her white blood cell’s production of antibodies to the NMDA receptors in her brain. In fact, antibodies to
NMDA receptors are found in 1-10% of those with diagnoses of schizophrenia (Müller et al., 2015;
Pollack, McCormack, Peakman, Nicholson, & David, 2014; Teixeira, Rocha, & Zhang, 2017). Also of
relevance, the recognition that inflammation in the brain can manifest behaviorally in psychosis explains
why symptoms of psychosis are found in those with brain inflammatory states associated with viral
infections and various autoimmune diseases (Müller et al., 2015).
Perhaps in the near future, the recognition that brain inflammation can manifest as symptoms of
schizophrenia and mania, as occurred for Susannah Cahalan, will call into question the diagnostic
categories in the Diagnostic and Statistical Manual of the American Psychiatric Association. In fact,
many have questioned whether Bipolar Disorder I and Schizophrenia share a common underlying
causation and should be considered variations of the same disorder (Berk et al, 2011; Clementz et al.,
2016; Guloksuz & van Os, 2017; Kuswanto et al., 2016).
What Can Be Done to Lower Inflammation?
Enhancing Vagal Tone
The Parasympathetic Nervous System (PNS) is a branch of the nervous system that controls
internal organs and the vasculature. The PNS also sends projections to the lymph nodes, where white
blood cells reside. The PNS can downregulate inflammation (Chavan, Pavlov, & Tracey, 2017; Pavlov &
Tracey, 2017). A measurable read out of the strength of the PNS (called vagal tone) is heart rate
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variability. Greater heart rate variability is better because it reflects better coordination between breathing
and heart rate (Porges, 2007, 2011). Moreover, heart rate variability correlates positively with capacity
for social engagement and better control over reactions to stress (Quintana, Kemp, Alvares, & Guastella,
2013).
There are many ways to increase vagal tone: meditation and yoga (Kiecolt-Glaser et al. 2010;
Pace et al., 2009); cheap biofeedback equipment (Lehrer et al., 2003; 2006; Lehrer & Gevirtz, 2014) and,
similarly, a phone app with breathing instruction called “the stress doctor” marketed by azumio (Littrell,
2015, p. 164); aerobic exercise (Coats et al., 1992; Hansen, Johnsen, Sollers, Stenvik, & Thayer, 2004);
and time spent with trusted companions (Grippo et al., 2007; 2009; Kemp et al., 2012) or engaging in prosocial care-giving (Eisenberger & Cole, 2012; Quintana et al., 2013) which release oxytocin which, in
turn, increases vagal tone.
Healthy Life Style
Exercise can prevent the rise of inflammatory factors elicited by stress (Hamer & Steptoe, 2007;
Mathur & Pedersen, 2008), has anti-depressant effects (Babyak et al., 2000; Hoffman et al., 2011) and
improves cognition in those with psychosis (Pajonk et al., 2010). Getting adequate sleep is important
because sleep deprivation is inflammatory (Irwin, Wang, Campomayer, Collado-Hidalgo, & Cole, 2006;
Zielinski et al., 2017). Yoga ameliorates mental distress and decreases inflammation (Balasubramaniam,
Telles, & Doraiswamy, 2013; Black et al., 2013; Khalsa, 2013; Kiecolt-Glaser et al., 2010) and increases
the expression of proteins needed for fighting viruses and cancer (Cole, 2014).
Dietary Interventions
Omega-3s are a type of fat richly abundant in seafood as well as other foods. There are receptors
for omega-3 metabolites on white blood cells which slow down inflammation (Serhan, 2017). Omega-3s
increase vagal tone (Hansen, Johnsen, Sollers, Stenvik & Thayer, 2004; La Rovere & Christensen, 2015)
and promote a healthy gut environment (Forsythe, Sudo, Dinan, Taylor, & Bienenstock, 2010). Sublette,
Ellis, Geant, & Mann (2011) evaluated the studies that employed omega-3s as a treatment for depression
concluding that they do work. However, the optimal balance is greater than 60% EPA and less than 40%
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DHA. In terms of other things to eat, curcumin, found in the Indian spice turmeric, is anti-inflammatory
(Aggarwal, 2010; Lopresti et al., 2014; Shehzad, Rehman, & Lee, 2013) and does reduce symptoms of
depression (Ng, Koh, Chan, Ho, 2017).
The research on omega-3s and mental health is new and funding for studies is less available than
for pharmaceutical treatments. Thus, strong evidence is lacking. A Cochrane Review by Appleton,
Sallis, Perry, Ness, and Churchill (2015) concluded that there was not yet sufficient high quality evidence
to determine efficacy in treating major depression. Another Cochrane Review by Montgomery and
Richardson (2008) also concluded there was insufficient evidence for making recommendations on
omega-3s for bipolar disorder as did a Cochrane Review by Irving, Mumby-Croft, and Joy (2011) on
omega-3s supplementation for schizophrenia.
The Microbiome
Attention has been focused recently on the microbes which live within us and outnumber the cells
which belong to us (Cryan & Dinan, 2012). The species of bacteria that one harbors in the gut influence
both mood and behavior. In a particularly convincing demonstration, Bercik et al. (2011) transferred the
fecal contents from an intrepid mouse strain into the digestive tracks of a timid strain of mice as well as
the reverse transfer. They showed that exploratory behavior ranging from timid to bold was determined
by the type of fecal transfer. The timid mice were emboldened by the transplant of the intrepid mice
feces. The intrepid mice became timid upon receipt of the feces from the timid mice. Not only did the
fecal transplants impact the exploratory behavior of the mice, but there were commensurate changes in
growth factors in relevant areas of the brain. Similar experiments have shown that fecal transplants from
obese mice can make the thin mice obese (Collins, Kassam, & Bercik, 2013; Turnbaugh et al., 2006).
Particular gut microbiota correlate with behavioral characteristics in humans and mice. Recovery
from psychosis is more likely in those with microbiota compositions more similar to those without a
mental health diagnosis (Schwarz et al., 2017). Those with depression have an elevated occurrence of
leaky gut (Maes, Kubera, Leunis, & Berk, 2012) and differences in microbiota composition (Jiang et al.,

Psychoneuroimmunology

12

2015). In work with hamsters which were engaged in an aggressive conflict, gut microbiota composition
predicted which animal would win the conflict (Partrick et al., 2018).
What changes the gut microbiome? Stress encourages colonization by inflammatory
microbiota species (Bangsgaard-Bendtsen et al., 2012; Rieder, Wisniewski, Alderman, & Campbell
2017; Watanabe, Arase, Nagaoka, Kawai, & Matsumoto, 2016), decreases the tight junctions which
prevent microbes from exiting the gut and moving into circulation (thereby resulting in systemic
inflammation) (Dinan & Cryan, 2012; Kiliaan et al., 1998), and decreases species diversity in the gut and
reduces Latobacillus (which will be discussed later) (Partrick, et al., 2018). Exercise encourages antiinflammatory species in the gut (Cook et al., 2016).
Diet has a major impact on the types of microbes found in the gut. Chassaing et al. (2017)
showed that emulsifiers, which are added to many foods (e.g., bread, ice cream) to extend shelf life,
change the composition of the microbiome and result in systemic inflammation. High fat diet does result
in changes in microbiota and low-grade inflammation (Breitin, Gewirtz, & Chassaing, 2018).
Consumption of fiber (for example, in apples) encourages anti-inflammatory varieties of microbiota
(Macia et al., 2015; Tan et al., 2016); and yields a thicker protective mucosal layer in the gut creating a
barrier so that bacteria cannot move into the blood stream (Breitin et al., 2018).
Some foods, called probiotics, actually introduce new bacteria into the gut. Yogurt and
fermented milk products contain bacteria (e.g., Lactobacillus casei). Work with rodents showed that
consumption of fermented milk products can prevent the stress-induced increase in inflammatory factors
in brain (Ait-Belgnaoui et al., 2012) and can attenuate the stress-response of leaky gut and subsequent rise
in the stress hormones cortisol and adrenaline (Ait-Belgnaoui et al., 2014). Research with people has
shown that for those women who are high on a neuroticism scale, those who consumed more fermented
milk products subsequently scored lower on a measure of social anxiety (Hilimire, DeVylder, & Forestell,
2015). Benton, Williams, and Brown (2007) found that for those with highest scores on depressed mood
scale, probiotic consumption resulted in improved mood compared to placebo. Tillisch et al. (2013) had
women consume fermented milk products for 4 weeks and then imaged their brains as they looked at
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angry and fearful faces. Those women who had consumed fermented milk products exhibited less
activity in areas of the brain involved in processing negative emotions (amygdala and the insula).
Presently, only a few randomized, placebo-controlled trials of probiotics have been conducted on
clinical samples. In a randomized, double-blind, placebo-controlled study of persons with major
depression, Akkasheh et al. (2016) found greater reduction of Beck depression scores as well as greater
reduction on an inflammatory index in those consuming fermented milk products for 8 weeks. In a metaanalysis of 10 placebo-controlled, randomized, double-blind trials of fermented milk products compared
to placebo including persons with depression and those without, Ng, Peters, Ho, Lim, and Yeo (2018)
failed to find a difference in depression scores for the full sample. However, a sub-analysis of those with
mild to moderate depression found lower depression scores for the probiotic group. There are fewer
studies of probiotics in those with psychosis, although a negative trial of probiotics for those with
schizophrenia was reported by Dickerson et al. (2014). A later study found that probiotics reduced the
rate of rehospitalization in those with acute mania (Dickerson et al., 2018). Little information is yet
available with regard to dosing, optimal delivery methods, and optimal species of bacteria to include in
the probiotic.
Caveats
How strong is the case for inflammation being linked with behavioral outcomes? The
manipulated variable research with animals and people provides the strongest support. With regard to
questions such as how many individuals carrying particular diagnoses can be considered to be in
inflammatory state, definitive answers are elusive. First, the lack of reliability of DSM diagnoses are
legendary and have been criticized by leaders in our field (see Kirk & Kutchins, 1992). Failure to
correctly classify individuals will mitigate finding relationships with other variables. Second, agreement
on optimal measures of inflammation are lacking. Indeed, Del Guidice and Gengestad (2018) recently
offered a well-reasoned critique on the use of often relied upon indicators of inflammation (viz.,
interleukin 6 and CRP) suggesting that often these measures reflect anti-inflammatory processes. Third,
the categories in the DSM rely on symptoms, many of them requiring subjective judgements of the client,
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not measures of what actually is happening in the brain/body. Perhaps, in the future, the categories in the
DSM will be reorganized.such that depressive behaviors associated with inflammation will be categorized
as a disorder distinct from depressive behaviors associated with some other underlying cause, whatever
that might be. However, before this can occur, a consensus on the best method for diagnosing brain
inflammation (brain imaging, spinal tap, blood markers, various types of antibodies) must emerge.
The reader may have noticed that many ways of influencing inflammation were discussed in the
section on interventions. Unfortunately, it is not yet known which are the most powerful influences and
whether, for example, consuming more omega-3s can offset a high rate of consumption of foods
containing preservatives. Studies evaluating foods must ensure that the nutrient is absorbed properly. For
example, curcumin absorbs better when consumed with black pepper (Aggarwal, 2011). Beyond this, the
recent Cochrane Review failing to find a beneficial effect of omega-3 consumption on cardiovascular
mortality, albeit finding some reduction in combined heart and stroke events (Abdelhamid et al. 2018)
raises additional issues. Many of the studies in the Abdelhamid et al. review considered omega-3
capsules. Would the same results have been found if the omega-3 were consumed in food sources such as
fresh fish, flaxseeds, chia seeds, or walnuts?

In the future, there may be studies offering more definitive

statements regarding optimal ways to consume beneficial nutrients for best absorption and which are the
most important foods to eat and which foods should be avoided. While strong scientific evidence is
lacking regarding any one particular influence on inflammation, it should be noted that the ways to
decrease inflammation reviewed here are generally consistent with the “heart healthy diet” and the
admonition to “move more” as recommended by the American Heart Association. What is new here is
that a healthy life-style is now recognized as impacting mental health as well as physical health.
Questions regarding the strength of these life style changes on mental health are not yet available.
How Social Workers Can Use this Information?
Direct practice social workers do work with clients who are sometimes experiencing considerable
distress and dysfunction. Generally, the focus is on optimizing talk therapy interventions and compliance
with treatment recommendations. The findings presented here suggest that ignoring diet and sedentary
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behavior can undermine the positive effects of psychosocial interventions. Thus, knowledge regarding the
impact of life style choices can enhance direct practice social work interventions. For macro-practice
social workers, the findings presented here underscore the importance of access to nutritional food, access
to safe places for exercise, and the availability of time for food preparation and exercise. Fortunately, a
literature has emerged on interventions for increasing access to good nutrition and evaluating these
interventions (see Fowler & Giger, 2017; Society for Public Health Education, 2015; Taillie et al., 2017).
Factors such as capacity for establishing a healthy life style should be included in measures of social
justice. Moreover, the public needs to demand that the food industry comply with health promoting
standards.
Social workers do help clients identify meaning in life and they help clients strive toward
meaningful relationships with others. When people feel connection to others and feel their lives have a
purpose, then inflammation is decreased (Fredrickson et al., 2015; Frederickson et al., 2013; Moleni etal.,
2015). Changes in diet, exercise patterns, vagal tone provide measurable, achievable goals that, when
realized, can decrease inflammation and thereby ameliorate disorders and foster resilience. Social
workers are in the business of helping clients make life style changes. The information presented here
provide a rough guide social workers in knowing which life style changes to encourage.
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